Ann: Mayne Pharma appoints new CFO, page-17

Let’s not get too excited just yet. There have
been a few false starts in last 5 years. Nuvaring
being a standout. Richards treated as a learning
curve instead of employing expertise to gain
FDA approval. Previous board members may
have hamstrung him to some degree. Who knows ?
Nextellis is fastest growing branded contraceptive
probably means other generics are outpacing it.
I’m not sure why a woman who has been using
a particular pill for years without any problems
would change script anyway. We may have to
wait for younger generation and current users who
for whatever reason need to change. This may
well take longer than expected to achieve $200m
revenue. Fingers crossed all the same..